Nomogram line crossing after acetaminophen combination product overdose

Ronald I Kirschner, Christina M. Rozier, Lynette M Smith, Kathy L. Jacobitz

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The Rumack-Matthew nomogram predicts the risk of hepatotoxicity following acute acetaminophen overdose based on a serum concentration obtained ≥4-hour post-ingestion. Some patients with low-risk concentrations at 4 hours may have subsequent values indicating increased risk (above the nomogram treatment line), especially if coingestants that slow gastrointestinal motility are involved. The treatment line currently used to identify low risk patients in the United States, Canada, and Australia begins at 150 mcg/mL (993 mol/L) and intersects at 18.75 mcg/mL (124.1 mol/L) 16 hours post-ingestion. Objective: To determine the incidence of nomogram line crossing after acute overdose of acetaminophen combination products containing an opioid or antihistamine. Methods: This was a prospective cohort study of hospitalized patients reported to a regional poison center (RPC) after acute overdose of a combination product containing an opioid or antihistamine. If a 4-hour acetaminophen concentration was detectable but below the nomogram treatment line, the RPC recommended repeat concentrations. Patients were entered into the study if at least one subsequent concentration was available. During follow-up calls hospital providers were queried regarding clinical features, treatment, and indicators of liver injury. Results: Over a 4-year period 76 patients met entry criteria. 5/76 (6.6%) had measureable acetaminophen concentrations below the treatment line at or close to 4-hour post-ingestion followed by values above the line obtained at 6.5-12.5 hours. Four of the five were treated with acetylcysteine and none developed hepatotoxicity. Four of the five had clinical features reported to the RPC suggesting toxicity from the opioid or antihistamine component. Conclusion: After acute overdose of acetaminophen combination products, patients with detectable but non-toxic 4-hour acetaminophen concentrations should have repeat concentrations obtained in a time frame that would allow providers to initiate acetylcysteine treatment, if needed, without undue delay.

Original languageEnglish (US)
Pages (from-to)40-46
Number of pages7
JournalClinical Toxicology
Volume54
Issue number1
DOIs
StatePublished - Jan 2 2016

Fingerprint

Nomograms
Acetaminophen
Poisons
Histamine Antagonists
Opioid Analgesics
Eating
Acetylcysteine
Therapeutics
Gastrointestinal Motility
Liver
Canada
Toxicity
Cohort Studies
Prospective Studies
Incidence
Wounds and Injuries
Serum

Keywords

  • Paracetamol
  • combination products
  • nomogram

ASJC Scopus subject areas

  • Toxicology

Cite this

Nomogram line crossing after acetaminophen combination product overdose. / Kirschner, Ronald I; Rozier, Christina M.; Smith, Lynette M; Jacobitz, Kathy L.

In: Clinical Toxicology, Vol. 54, No. 1, 02.01.2016, p. 40-46.

Research output: Contribution to journalArticle

Kirschner, Ronald I ; Rozier, Christina M. ; Smith, Lynette M ; Jacobitz, Kathy L. / Nomogram line crossing after acetaminophen combination product overdose. In: Clinical Toxicology. 2016 ; Vol. 54, No. 1. pp. 40-46.
@article{30c2246f1aaf4b1ea409471b842caf75,
title = "Nomogram line crossing after acetaminophen combination product overdose",
abstract = "Background: The Rumack-Matthew nomogram predicts the risk of hepatotoxicity following acute acetaminophen overdose based on a serum concentration obtained ≥4-hour post-ingestion. Some patients with low-risk concentrations at 4 hours may have subsequent values indicating increased risk (above the nomogram treatment line), especially if coingestants that slow gastrointestinal motility are involved. The treatment line currently used to identify low risk patients in the United States, Canada, and Australia begins at 150 mcg/mL (993 mol/L) and intersects at 18.75 mcg/mL (124.1 mol/L) 16 hours post-ingestion. Objective: To determine the incidence of nomogram line crossing after acute overdose of acetaminophen combination products containing an opioid or antihistamine. Methods: This was a prospective cohort study of hospitalized patients reported to a regional poison center (RPC) after acute overdose of a combination product containing an opioid or antihistamine. If a 4-hour acetaminophen concentration was detectable but below the nomogram treatment line, the RPC recommended repeat concentrations. Patients were entered into the study if at least one subsequent concentration was available. During follow-up calls hospital providers were queried regarding clinical features, treatment, and indicators of liver injury. Results: Over a 4-year period 76 patients met entry criteria. 5/76 (6.6{\%}) had measureable acetaminophen concentrations below the treatment line at or close to 4-hour post-ingestion followed by values above the line obtained at 6.5-12.5 hours. Four of the five were treated with acetylcysteine and none developed hepatotoxicity. Four of the five had clinical features reported to the RPC suggesting toxicity from the opioid or antihistamine component. Conclusion: After acute overdose of acetaminophen combination products, patients with detectable but non-toxic 4-hour acetaminophen concentrations should have repeat concentrations obtained in a time frame that would allow providers to initiate acetylcysteine treatment, if needed, without undue delay.",
keywords = "Paracetamol, combination products, nomogram",
author = "Kirschner, {Ronald I} and Rozier, {Christina M.} and Smith, {Lynette M} and Jacobitz, {Kathy L.}",
year = "2016",
month = "1",
day = "2",
doi = "10.3109/15563650.2015.1110591",
language = "English (US)",
volume = "54",
pages = "40--46",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Nomogram line crossing after acetaminophen combination product overdose

AU - Kirschner, Ronald I

AU - Rozier, Christina M.

AU - Smith, Lynette M

AU - Jacobitz, Kathy L.

PY - 2016/1/2

Y1 - 2016/1/2

N2 - Background: The Rumack-Matthew nomogram predicts the risk of hepatotoxicity following acute acetaminophen overdose based on a serum concentration obtained ≥4-hour post-ingestion. Some patients with low-risk concentrations at 4 hours may have subsequent values indicating increased risk (above the nomogram treatment line), especially if coingestants that slow gastrointestinal motility are involved. The treatment line currently used to identify low risk patients in the United States, Canada, and Australia begins at 150 mcg/mL (993 mol/L) and intersects at 18.75 mcg/mL (124.1 mol/L) 16 hours post-ingestion. Objective: To determine the incidence of nomogram line crossing after acute overdose of acetaminophen combination products containing an opioid or antihistamine. Methods: This was a prospective cohort study of hospitalized patients reported to a regional poison center (RPC) after acute overdose of a combination product containing an opioid or antihistamine. If a 4-hour acetaminophen concentration was detectable but below the nomogram treatment line, the RPC recommended repeat concentrations. Patients were entered into the study if at least one subsequent concentration was available. During follow-up calls hospital providers were queried regarding clinical features, treatment, and indicators of liver injury. Results: Over a 4-year period 76 patients met entry criteria. 5/76 (6.6%) had measureable acetaminophen concentrations below the treatment line at or close to 4-hour post-ingestion followed by values above the line obtained at 6.5-12.5 hours. Four of the five were treated with acetylcysteine and none developed hepatotoxicity. Four of the five had clinical features reported to the RPC suggesting toxicity from the opioid or antihistamine component. Conclusion: After acute overdose of acetaminophen combination products, patients with detectable but non-toxic 4-hour acetaminophen concentrations should have repeat concentrations obtained in a time frame that would allow providers to initiate acetylcysteine treatment, if needed, without undue delay.

AB - Background: The Rumack-Matthew nomogram predicts the risk of hepatotoxicity following acute acetaminophen overdose based on a serum concentration obtained ≥4-hour post-ingestion. Some patients with low-risk concentrations at 4 hours may have subsequent values indicating increased risk (above the nomogram treatment line), especially if coingestants that slow gastrointestinal motility are involved. The treatment line currently used to identify low risk patients in the United States, Canada, and Australia begins at 150 mcg/mL (993 mol/L) and intersects at 18.75 mcg/mL (124.1 mol/L) 16 hours post-ingestion. Objective: To determine the incidence of nomogram line crossing after acute overdose of acetaminophen combination products containing an opioid or antihistamine. Methods: This was a prospective cohort study of hospitalized patients reported to a regional poison center (RPC) after acute overdose of a combination product containing an opioid or antihistamine. If a 4-hour acetaminophen concentration was detectable but below the nomogram treatment line, the RPC recommended repeat concentrations. Patients were entered into the study if at least one subsequent concentration was available. During follow-up calls hospital providers were queried regarding clinical features, treatment, and indicators of liver injury. Results: Over a 4-year period 76 patients met entry criteria. 5/76 (6.6%) had measureable acetaminophen concentrations below the treatment line at or close to 4-hour post-ingestion followed by values above the line obtained at 6.5-12.5 hours. Four of the five were treated with acetylcysteine and none developed hepatotoxicity. Four of the five had clinical features reported to the RPC suggesting toxicity from the opioid or antihistamine component. Conclusion: After acute overdose of acetaminophen combination products, patients with detectable but non-toxic 4-hour acetaminophen concentrations should have repeat concentrations obtained in a time frame that would allow providers to initiate acetylcysteine treatment, if needed, without undue delay.

KW - Paracetamol

KW - combination products

KW - nomogram

UR - http://www.scopus.com/inward/record.url?scp=84951567013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951567013&partnerID=8YFLogxK

U2 - 10.3109/15563650.2015.1110591

DO - 10.3109/15563650.2015.1110591

M3 - Article

C2 - 26567585

AN - SCOPUS:84951567013

VL - 54

SP - 40

EP - 46

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 1

ER -